NexLife pharmacy: 503A or 503B, and how to check
Which pharmacies NexLife's plan pages name, why the list on this page changed, and how to check a compounding pharmacy's license before your first order.
NexLife is a telehealth company, not a pharmacy. Its plan pages, read November 6, 2026, name three state-licensed 503A compounding pharmacies: Absolute Pharmacy (Lutz, FL), Premium Compounding (Decatur, AL) and Boudreaux's New Drug Store (Lake Charles, LA). No 503B outsourcing facility is named. The five-pharmacy network this page listed before (Red Rock, Hallandale, Absolute, Empower, DIRx) is withdrawn. We have not yet checked the three licenses on state board sites; you can, in a few minutes.
Which pharmacies does NexLife name?
| Pharmacy | City, state | Type stated | License checked by us |
|---|---|---|---|
| Absolute Pharmacy | Lutz, FL | State-licensed 503A | Not yet |
| Premium Compounding | Decatur, AL | State-licensed 503A | Not yet |
| Boudreaux's New Drug Store | Lake Charles, LA | State-licensed 503A | Not yet |
The plan pages do not say which of the three fills a given order. Ask NexLife which pharmacy will fill yours, and check the name on the label when it arrives.
Why did the pharmacy list change?
Earlier editions of this page listed Red Rock, Hallandale, Absolute, Empower and DIRx, and described NexLife as using "503A & 503B pharmacies". The plan pages we read name only the three pharmacies above and describe them as 503A. Nothing we read supports the longer list or a 503B partner, so we withdrew both.
What is the difference between NexLife, a 503A pharmacy and a 503B facility?
| Entity | What it means |
|---|---|
| Telehealth company | Arranges the visit, prescription and shipping. NexLife is this. Not a pharmacy, not a manufacturer. |
| 503A pharmacy | State-licensed. Compounds for an individual patient against a prescription. Overseen mainly by the state board of pharmacy. |
| 503B outsourcing facility | Registered with FDA. May compound in bulk without patient-specific prescriptions. Subject to CGMP inspection. |
| Manufacturer | Makes the FDA-approved product: Novo Nordisk for Wegovy and Ozempic. |
| Compounded preparation | Not FDA-approved. No premarket review of safety, effectiveness or quality. |
There is no such thing as an "FDA-approved pharmacy". A pharmacy is state-licensed or FDA-registered, and neither status makes a compounded drug FDA-approved. On April 30, 2026, FDA proposed not to place semaglutide, tirzepatide or liraglutide on the 503B bulks list (91 FR 23431); we found no final decision as of October 15, 2026. That proposal concerns 503B facilities; NexLife names none.
How can you check each pharmacy's license?
- Get the exact legal name and state of the pharmacy that will fill your order, from NexLife or your vial label.
- Look up the license on that state's board of pharmacy site. For these three, that means the Florida, Alabama and Louisiana boards. Check that the license is active and note any disciplinary action.
- If you live in another state, check the non-resident license. A pharmacy shipping to you usually needs a license in your state too; your own state board can confirm it.
- Search FDA's warning-letter database for the pharmacy's name.
- If a 503B facility is ever named, check FDA's registered outsourcing facilities list.
To check a compounded semaglutide program as of November 2026, get the dispensing pharmacy's legal name and state from the program or your vial label, then look the license up on that state board of pharmacy's website, and for a 503B outsourcing facility on FDA's registered-outsourcing list. Search FDA's warning-letter database for the pharmacy's name. A program that will not name its pharmacy before you pay leaves you unable to make any of these checks, so treat that refusal as a reason to look elsewhere. Our pharmacy check guide has the full steps.
What should you ask NexLife, or any program, about the pharmacy?
- Which pharmacy will fill my prescription, by name?
- Is it a 503A or a 503B facility, and in which state is it licensed?
- What form of semaglutide does it use? FDA warns that salt forms such as semaglutide sodium or acetate are not the active ingredient in any approved drug.
- Is the vial single-dose or multi-dose? FDA's October 1, 2026 page gives a 28-day discard rule for compounded multi-dose GLP-1 vials.
- Has the pharmacy received an FDA warning letter or a state board action?
Who prescribes, and who is the medical director?
NexLife's plan pages place provider review and medical guidance with NexLife Medical Group, and NexLife names Adam Kennah, M.D. as medical director. You can look up any prescriber's license on the state medical board site and the NPI registry.
Sources
- NexLife, semaglutide plans, read November 6, 2026.
- Semaglutide Watchdog, data/prices.json, data/facts.json and data/price-history-2026.json, November 9, 2026 (CC BY 4.0).
- FDA warning letter 738238, Empower Clinic Services, LLC dba Empower Pharmacy, dated September 18, 2026, posted September 22, 2026; read October 15, 2026.
- FDA, 503B bulks list proposal, April 30, 2026 (91 FR 23431); comment period extended to July 30, 2026 (91 FR 38719).
- FDA, Concerns with Unapproved GLP-1 Drugs Used for Weight Loss, current as of October 1, 2026.
- FDA, Registered Outsourcing Facilities.
Frequently asked questions
Is NexLife a 503A or 503B pharmacy?
Neither. NexLife is a telehealth company, not a pharmacy. Its plan pages, read November 6, 2026, name three state-licensed 503A compounding pharmacies that fill its prescriptions: Absolute Pharmacy in Lutz, Florida; Premium Compounding in Decatur, Alabama; and Boudreaux's New Drug Store in Lake Charles, Louisiana. No 503B outsourcing facility is named on those pages.
Does NexLife use Empower Pharmacy?
NexLife's plan pages do not name Empower. An older edition of this page listed Empower in a five-pharmacy network that the plan pages do not support, and we withdrew it. FDA sent Empower warning letter 738238 on September 18, 2026. That letter is about Empower; it says nothing about NexLife.
What is the difference between a 503A and a 503B pharmacy?
A 503A pharmacy is state-licensed and compounds for an individual patient against a prescription. A 503B outsourcing facility registers with FDA, may compound in bulk and is subject to CGMP inspection. Neither makes the compounded product FDA-approved. Registration is per facility, so ask which facility fills your prescription.
How do I check a compounding pharmacy's license?
Get the pharmacy's legal name and state from the program or your vial label. Look up the license on that state's board of pharmacy site and confirm it is active. Check whether it holds a non-resident license for your state. Then search FDA's warning-letter database for the name, and for a 503B, FDA's registered outsourcing facilities list.
Is NexLife's compounded semaglutide FDA-approved?
No. Compounded semaglutide is not FDA-approved, and FDA does not review a compounder's formulation, strength or sterility before it is sold. It is made with the drug in Wegovy and Ozempic, but it is not the same product. That applies to every compounded semaglutide program, whichever pharmacy fills it.